Trial intelligence / Profile preview

Combined Iron Protocols in Major Cardiac Surgery

NCT06012760Recruiting

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Jan 2025
Primary completion
Jan 2028
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Randomised trial of iron sucrose, erythropoietin and ascorbic acid in iron deficiency anemia (IDA) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Perioperative allogeneic red blood cell transfusion volume at 5 days. Started Jan 2025; status: recruiting.

02

Drugs

iron sucroseerythropoietinascorbic acid
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT06012760.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06012760.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call